APA (7th ed.) Citation

Sun, Y., Li, W., Chen, N., Zhang, N., Hu, G., Xie, F., . . . Ma, J. (2016). Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A phase 3, multicentre, randomised controlled trial. The lancet oncology, 17(11), 1509-1520. https://doi.org/10.1016/S1470-2045(16)30410-7

Chicago Style (17th ed.) Citation

Sun, Ying, et al. "Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multicentre, Randomised Controlled Trial." The Lancet Oncology 17, no. 11 (2016): 1509-1520. https://doi.org/10.1016/S1470-2045(16)30410-7.

MLA (9th ed.) Citation

Sun, Ying, et al. "Induction Chemotherapy Plus Concurrent Chemoradiotherapy Versus Concurrent Chemoradiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: A Phase 3, Multicentre, Randomised Controlled Trial." The Lancet Oncology, vol. 17, no. 11, 2016, pp. 1509-1520, https://doi.org/10.1016/S1470-2045(16)30410-7.